Zhejiang Shengda Pharm (603079) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.028x

Based on the latest financial reports, Zhejiang Shengda Pharm (603079) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥45.27 Million ≈ $6.62 Million USD) by net assets (CN¥1.60 Billion ≈ $234.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Zhejiang Shengda Pharm stock valuation for the company's overall valuation and market capitalisation.

Zhejiang Shengda Pharm - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Zhejiang Shengda Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Shengda Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Shengda Pharm ranked by their cash flow conversion efficiency. Explore Zhejiang Shengda Pharm earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Long Yuan Construction Group Co Ltd SHG:600491	0.027x
Qingdao Foods Co Ltd SHE:001219	0.070x
Bsm Chemical Co Ltd SHE:300796	0.056x
Hanwha Galleria Corp. KO:452260	N/A
Solus Advanced Materials Co Ltd KO:336370	0.006x
AVI Japan Opportunity Trust PLC LSE:AJOT	0.000x
Bigcommerce Holdings Inc NASDAQ:BIGC	0.350x
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited F:GU5	0.050x

Annual Cash Flow Conversion Efficiency for Zhejiang Shengda Pharm (2012–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Shengda Pharm from 2012 to 2025. View 603079 stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.61 Billion ≈ $236.30 Million	CN¥138.88 Million ≈ $20.32 Million	0.086x	-25.32%
2024-12-31	CN¥1.28 Billion ≈ $187.89 Million	CN¥147.88 Million ≈ $21.64 Million	0.115x	+127.05%
2023-12-31	CN¥1.27 Billion ≈ $185.84 Million	CN¥64.42 Million ≈ $9.43 Million	0.051x	+67.37%
2022-12-31	CN¥1.34 Billion ≈ $196.59 Million	CN¥40.72 Million ≈ $5.96 Million	0.030x	-45.58%
2021-12-31	CN¥1.34 Billion ≈ $195.64 Million	CN¥74.46 Million ≈ $10.90 Million	0.056x	-77.85%
2020-12-31	CN¥1.33 Billion ≈ $193.90 Million	CN¥333.20 Million ≈ $48.76 Million	0.251x	+291.54%
2019-12-31	CN¥911.71 Million ≈ $133.41 Million	CN¥58.55 Million ≈ $8.57 Million	0.064x	-40.01%
2018-12-31	CN¥828.42 Million ≈ $121.22 Million	CN¥88.69 Million ≈ $12.98 Million	0.107x	-13.68%
2017-12-31	CN¥768.71 Million ≈ $112.49 Million	CN¥95.33 Million ≈ $13.95 Million	0.124x	-25.25%
2016-12-31	CN¥440.02 Million ≈ $64.39 Million	CN¥73.00 Million ≈ $10.68 Million	0.166x	-50.80%
2015-12-31	CN¥439.09 Million ≈ $64.25 Million	CN¥148.07 Million ≈ $21.67 Million	0.337x	+218.46%
2014-12-31	CN¥324.87 Million ≈ $47.54 Million	CN¥34.40 Million ≈ $5.03 Million	0.106x	-71.73%
2013-12-31	CN¥281.09 Million ≈ $41.13 Million	CN¥105.28 Million ≈ $15.41 Million	0.375x	-36.72%
2012-12-31	CN¥185.99 Million ≈ $27.22 Million	CN¥110.08 Million ≈ $16.11 Million	0.592x	--

About Zhejiang Shengda Pharm

SHG:603079 China Drug Manufacturers - Specialty & Generic

Market Cap

$362.64 Million

CN¥2.48 Billion CNY

Market Cap Rank

#14037 Global

#4230 in China

Share Price

CN¥13.11

Change (1 day)

-1.28%

52-Week Range

CN¥10.04 - CN¥21.99

All Time High

CN¥53.01